In 2030, the Synthetic Biology Market will reach USD 87 Billion

VANCOUVER in BC, Feb. 6, 2023 /PRNewswire/ — The synthetic biology market size reached USD 10.35 Billion According to the latest analysis, it is projected that 2021 will see a 26.7% CAGR during the forecast period. Emergen Research. Rising research and development activities in this field of synthetic biology, growing application of synthetic biology including living biotherapeutics, multiplexed diagnostics, and third-generation biorefineries as well rising investments towards synthetic biology start-ups developing tools and services are some key factors driving synthetic biology market revenue growth.



Synthetic biology is a rapidly growing area that uses engineering and scientific principles to design and manage living systems. This allows for technological advances that could have a significant impact on the global economy. Producers are using this technology to produce high-performance, environmentally friendly products more efficiently. This has boosted market revenue growth. CRISPR/Cas9 has been a breakthrough in genome editing technology. There have also been advances in informatics and computational tools that have helped to lower the cost of DNA sequencing and synthesis.

To understand the complete structure of this report, request a free sample copy [Summary + TOC]) @

Already, synthetic biology has been used to modify human cells to cure diseases and to alter microbes to make important substances for industry. Startups in synthetic biology are developing more environmentally friendly products that utilize less water and land and don’t rely on fossil fuels or their byproducts. These products are also healthier and last longer, which contributes significantly to the industry’s growth.


Due to increased investments in synthetic biology start ups creating tools and services, the demand for synthetic biology devices is on the rise. In the last ten years, there have been more than 12 billion dollars In the synthetic biology sector, around $1.5 billion has been invested. These include approximately USD 4 Billion 2019 will see a large amount of funding from renowned biotechnology companies like Bayer, Novartis, and strong investment organisations like SoftBank, DCVC and a16z as well as startup accelerators Y Combinator or IndieBio. Major corporations and startups are developing products using synthetic biology, which is fueling the market’s growth. Take, for example, the on July 29, 2022German corporation Insempra announced that it has made a strategic investment into Solena Materials, a synthetic biology company. This is because Insempra uses biology to enable businesses to create superior products by working with nature. Solena is a company that develops high-performance textile fibres for clothing. Significant companies offering synthetic biology as a service only recently started to emerge. Ginkgo Bioworks and Zymergen were three of the companies that offered services to create genetically modified organisms. Synthace Biotechnology and Teselagen Biotechnology have developed AI-powered tools that can efficiently build DNA/RNA sequences.


The synthetic biology industry faces many challenges and issues. The significant biosafety concern in synthetic biology poses a significant obstacle to its growth. This includes the accidental or intentional release of synthetic organisms into the surrounding environment through experiments and other activities. The potential for synthetic microbes and bacteria to interact with other organisms can lead to contamination of the environment. They can also cross-pollinate with native species and disrupt ecosystems. The ethical challenges faced by engineers in synthetic biology go beyond those in other technical fields. This hinders the growth of the synthetic biology market.

Emergen Research offers a limited time discount (Grab a copy at a discounted price now)

Growth Projections

The market for synthetic biology is forecast to grow at a rate of 26.7% during the forecast period. Revenue is also expected to increase. USD 10.35 Billion To be available in 2021 USD 87 Billion 2030. Market revenue growth will be supported by rising spending in emerging markets.

Current Trends & Innovations

Rapid technological advances and a growing demand for engineered biotherapeutics are driving industry change. Synthetic biology technologies are evolving, with the potential to make practically anything competitively and sustainably. The synthetic biology industry is expanding at a rapid pace. Companies are using synthetic biology methods to create innovative products and processes, improve existing operations, and reduce costs to remain competitive. New advancements in bacterial and mammalian cell construction include the creation of cells that operate in biological materials or within the body as minimally invasive theranostics for the real-time regulation of complicated pathological states. A major upgrade in the field of theranostic cell engineering was FDA approval of tisagenlecleucel (Kymriah), the first gene therapy to be authorized in The United States. CAR-T cell therapy is a type of gene therapy that involves separating T cells from patients and genetically altering these cells to express a Chimeric Antigen Receptor (CAR) before bringing them back into the patient. These cells can live for years or even decades. Synthetic Biology is now more popular in the medical industry, which is driving the market’s growth.

Strategic Initiatives

Market report contains major companies like Amyris, Inc., Ginkgo Bioworks, Novozymes AG, Synbio Technology, Evonetix Ltd., Calyxt, Inc., Codex DNA, Inc., GenScript Corporation., Twist Biosciences, Eurofins Scientific, Inc.

  • On 12 August 2021Antheia is a synthetic biology company that develops future plant-inspired drugs. Ginkgo Bioworks is building the top horizontal platform to program cells. They announced a collaboration in order to speed up the discovery of and production of important drugs. Ginkgo helps clients in many industries to create better products. Antheia recently announced a merger with Soaring Eagle Acquisition Corp. Antheia plans to increase the number essential active pharmaceutical ingredients and start materials in its pipeline through Antheia’s high-throughput enzyme design and screening capabilities (KSMs).

View Full Report Description + Research Methodology + Table Of Content + Infographics@

Scope of Research

Report Details

The end result

Market size in 2021

USD 10.35 Billion

CAGR (2022–2030)

26.7 %

Revenue projections to 2030

USD 87 Billion

Base year for estimation


Historical data


Forecast period


Quantitative units

From 2022 to 2030, revenue in USD Millions and CAGR in percent

Report coverage

Forecast revenue, company ranking and competitive landscape, growth factors, trends

Segments covered

Type of product, technology, application, end-use, and location

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S.A. Canada, Mexico. Germany, France. U.K. Italy. Spain. Benelux. Rest of Europe. China. India. Japan. South Korea. Rest of APAC. Brazil. Rest of LATAM. Saudi Arabia. UAE. South Africa. Turkey. Rest of MEA

Key companies profiled

Amyris, Inc., Ginkgo Bioworks, Novozymes AG, Synbio Technologies, Evonetix Ltd., Calyxt, Inc., Codex DNA, Inc., GenScript Corporation., Twist Biosciences, Eurofins Scientific, Inc.

The scope of customization

10 hours of expert consultation and customization

You can request custom requirements for this report [Customization Available] @

Emergen Research segmented the market for synthetic biology Based on product, technology, app, end-use, region, and other factors:

  • Product Outlook (Revenue, USD Billion; 2019-2030)

  • Technology Outlook (Revenue USD billion; 2019-2030)

  • Application Outlook (Revenue, USD Billion; 2019-2030)

  • End-Use Outlook (Revenue, USD Billion; 2019-2030)

  • Regional Outlook (Revenue, USD billion, 2019 – 2030).

Emergen Research publishes the latest research reports

Gas Treatment MarketListed by Type (Amines or Non-Amines), Application (Dehydration, Acid Gas Removal) as well as Forecasted to 2030 by Region

Flight Simulator Market, By Methods (Synthetic, Virtual), By Types (Flight Training devices, Full Flight Simulators. Mission Flight Simulators and Fixed Base Simulators), And By Platform (Commercial or Military). Forecast to 2030

Electronic Flight Instrument System Market, By Platform (Commercial Aviation and Military Aviation and General Aviation), by Application By Fit (Linefit and Retrofit) and By Region Forecast to 2030

Space Cryogenics Market By Cooling Type: High Temperature and Low-Temperature Coolers, By Component Type: Low Conductive Supports and Multilayer Insulation. V-Groove shields. By Application and Region Forecast to 2030

Smart Shelves Market By Component (Hardware, Software & Solutions, and Professional Services), By Organization Size (Large Enterprises and Small & Medium-Sized Enterprises), By Application, and By Region Forecast to 2030

Connected Toys Market, By Application, Education and Entertainment, By Age Group (1-5, 6-8, 9-12, and Teenagers (13-19 years), By Distribution Channels (Online and Offline), And By Region Forecast to 2030

Negative Pressure Wound Therapy Market– By Product Type (Conventional, Single-Use and Accessories), By Wound Type, End-Use and Forecast to 2030

Hypercholesterolemia Market, By Disease Types (Genetic and Acquired), And By Treatment Types (Statins Bile-acid Binding Reins, Niacin, etc. ), By Distribution Channel (Hospital Pharmacies), Retail Pharmacies, and Other), Forecast to 2030

About Emergen Research

Emergen Research provides market research and consulting services. We offer customized research reports and syndicated reports. Our solutions focus solely on your goal to target, locate, and analyze consumer behaviour shifts across different demographics and across industries. We help clients make smarter business decision. Our market intelligence studies provide relevant, fact-based research across multiple industry sectors, such as Healthcare, Touch Points Chemicals, Types, Energy. Our research is constantly updated to keep our clients abreast of current market trends. Emergen Research employs a number of highly skilled analysts in a variety of areas. Our clients are able to gain an advantage over their competitors because of our industry experience and ability develop concrete solutions to research problems.

Contact us
Eric Lee
Corporate Sales Specialist
Emergen Research | Web:
Direct Line: (604) 757-9756
E-mail: [email protected]
Emergen Research Media Citations:
For more information, visit:
Explore Our Custom Intelligence services | Growth Consulting Services
Check out our Press Release @
Trending Titles LiDAR Market | Metaverse Market




See original content–emergen-research-301739366.html

SOURCE Emergen Research

Previous post Jack Henry Jakobik pledges his support for Tennessee
Next post Here are the essential facts to know before you file. How to quickly receive your refund